Allergan bid may be healthier for Teva than battle with Mylan
July 26, 2015 at 06:51 AM EDT
TEL AVIV, July 26 (Reuters) - After months of sparring in a hostile takeover bid for rival Mylan NV, Teva Pharmaceutical's move to buy Allergan Plc's generic drug business instead could be a smoother ride that will bring bigger returns, faster.